shutterstock_405634462
News
TEPOXX approved in Japan for treatment of orthopoxviruses
SIGA Technologies' antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as TPOXX in the United States, has received regulatory approval in Japan for the...
Candid Therapeutics enters agreement with WuXi Biologics on trispecific T-cell Engager
Candid Therapeutics, a clinical-stage biotechnology company focused on advancing T-cell engagers for autoimmune and inflammatory diseases, has entered an agreement with WuXi Biologics under...
GSK’s Nucala approved in China for adults with chronic rhinosinusitis with nasal polyps
The China National Medical Products Administration has approved GSK's Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with intranasal...
